Daniel G. Anderson
Daniel G. Anderson
Bestätigte E-Mail-Adresse bei mit.edu
TitelZitiert vonJahr
Knocking down barriers: advances in siRNA delivery
KA Whitehead, R Langer, DG Anderson
Nature reviews Drug discovery 8 (2), 129, 2009
Non-viral vectors for gene-based therapy
H Yin, RL Kanasty, AA Eltoukhy, AJ Vegas, JR Dorkin, DG Anderson
Nature Reviews Genetics 15 (8), 541, 2014
Delivery materials for siRNA therapeutics
R Kanasty, JR Dorkin, A Vegas, D Anderson
Nature materials 12 (11), 967, 2013
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
A Akinc, A Zumbuehl, M Goldberg, ES Leshchiner, V Busini, N Hossain, ...
Nature biotechnology 26 (5), 561, 2008
CRISPR-Cas9 knockin mice for genome editing and cancer modeling
RJ Platt, S Chen, Y Zhou, MJ Yim, L Swiech, HR Kempton, JE Dahlman, ...
Cell 159 (2), 440-455, 2014
Treating metastatic cancer with nanotechnology
A Schroeder, DA Heller, MM Winslow, JE Dahlman, GW Pratt, R Langer, ...
Nature Reviews Cancer 12 (1), 39, 2012
Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells
DG Anderson, S Levenberg, R Langer
Nature biotechnology 22 (7), 863, 2004
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
H Yin, W Xue, S Chen, RL Bogorad, E Benedetti, M Grompe, ...
Nature biotechnology 32 (6), 551, 2014
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
H Lee, AKR Lytton-Jean, Y Chen, KT Love, AI Park, ED Karagiannis, ...
Nature nanotechnology 7 (6), 389, 2012
Lipid-like materials for low-dose, in vivo gene silencing
KT Love, KP Mahon, CG Levins, KA Whitehead, W Querbes, JR Dorkin, ...
Proceedings of the National Academy of Sciences 107 (5), 1864-1869, 2010
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates
M Frank-Kamenetsky, A Grefhorst, NN Anderson, TS Racie, B Bramlage, ...
Proceedings of the National Academy of Sciences 105 (33), 11915-11920, 2008
Rational development of LEA29Y (belatacept), a high‐affinity variant of CTLA4‐Ig with potent immunosuppressive properties
CP Larsen, TC Pearson, AB Adams, P Tso, N Shirasugi, E StrobertM, ...
American Journal of Transplantation 5 (3), 443-453, 2005
Therapeutic siRNA silencing in inflammatory monocytes in mice
F Leuschner, P Dutta, R Gorbatov, TI Novobrantseva, JS Donahoe, ...
Nature biotechnology 29 (11), 1005, 2011
Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells
Y Mei, K Saha, SR Bogatyrev, J Yang, AL Hook, ZI Kalcioglu, SW Cho, ...
Nature materials 9 (9), 768, 2010
CRISPR-mediated direct mutation of cancer genes in the mouse liver
W Xue, S Chen, H Yin, T Tammela, T Papagiannakopoulos, NS Joshi, ...
Nature 514 (7522), 380, 2014
A combinatorial polymer library approach yields insight into nonviral gene delivery
JJ Green, R Langer, DG Anderson
Accounts of chemical research 41 (6), 749-759, 2008
Milk allergy: I. Oral challenge with milk and isolated milk proteins in allergic children
AS Goldman, DW Anderson, WA Sellers, S Saperstein, WT Kniker, ...
Pediatrics 32 (3), 425-443, 1963
Semi‐automated synthesis and screening of a large library of degradable cationic polymers for gene delivery
DG Anderson, DM Lynn, R Langer
Angewandte Chemie International Edition 42 (27), 3153-3158, 2003
Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library
DM Lynn, DG Anderson, D Putnam, R Langer
Journal of the American Chemical Society 123 (33), 8155-8156, 2001
Physical and mechanical properties of PLA, and their functions in widespread applications—A comprehensive review
S Farah, DG Anderson, R Langer
Advanced drug delivery reviews 107, 367-392, 2016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20